Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart scans aim to delay hormone therapy in prostate cancer patients

NCT ID NCT04175431

Recruiting now Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

First seen Dec 30, 2025 · Last updated May 08, 2026 · Updated 18 times

Summary

This study tests whether special PET/CT scans (PSMA or fluciclovine) can find small spots of prostate cancer that have spread beyond the prostate. By treating only those spots with targeted therapy, doctors hope to lower PSA levels and delay the need for long-term hormone therapy. The trial involves 100 men who have had their prostate removed and radiation, and now have a rising PSA between 0.2 and 10 ng/mL.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    RECRUITING

    Seattle, Washington, 98109, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Pittsburgh Cancer Institute (UPCI)

    RECRUITING

    Pittsburgh, Pennsylvania, 15232, United States

    Contact

Conditions

Explore the condition pages connected to this study.

PROSTATE ADENOCARCINOMA